There are two things, quickly.
One is, as I said, that it's impossible for the health protection branch to have the expertise to really do a good regulatory process of all drugs that the FDA sees. So they should coordinate and work together with the FDA and other agencies and save money.
Secondly, I just saw in the paper again today that we have 11 securities commissions across the country. There should be one. For somebody to raise the money.... I know that they've been working at it and it's been difficult to get, but that's an absolute no-brainer.
Also, coordinate the health protection branch with the FDA and the European EMA.